Anne R. Mccall to Humans
This is a "connection" page, showing publications Anne R. Mccall has written about Humans.
Connection Strength
0.136
-
Young and High Risk. Int J Radiat Oncol Biol Phys. 2020 12 01; 108(5):1132-1133.
Score: 0.024
-
In Reply to Trombetta. Int J Radiat Oncol Biol Phys. 2019 11 15; 105(4):904-905.
Score: 0.023
-
Linearly Accelerating Toward Gender Equity in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2019 08 01; 104(5):974-978.
Score: 0.022
-
A feasibility study of 2-mm bolus for postmastectomy radiation therapy. Pract Radiat Oncol. 2017 May - Jun; 7(3):161-166.
Score: 0.018
-
Communicating the Gynecologic Brachytherapy Experience (CoGBE): Clinician perceived benefits of a graphic narrative discussion guide. Brachytherapy. 2023 May-Jun; 22(3):352-360.
Score: 0.007
-
Local Control and Use of External Beam Parametrial Boost in the Era of Image-Guided Brachytherapy for Locally Advanced Cervical Cancer. Am J Clin Oncol. 2021 11 01; 44(11):565-571.
Score: 0.006
-
The use of complementary and integrative therapies as adjunct interventions during radiotherapy: a systematic review. Support Care Cancer. 2021 Nov; 29(11):6201-6209.
Score: 0.006
-
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity. Sci Transl Med. 2021 02 24; 13(582).
Score: 0.006
-
Physician review of image registration and normal structure delineation. J Appl Clin Med Phys. 2020 Nov; 21(11):80-87.
Score: 0.006
-
A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020 07 01; 107(3):487-498.
Score: 0.006
-
Communicating the External Beam Radiation Experience (CEBRE): Perceived Benefits of a Graphic Narrative Patient Education Tool. Pract Radiat Oncol. 2020 Jul - Aug; 10(4):e219-e226.
Score: 0.006
-
The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial. Biol Blood Marrow Transplant. 2003 Aug; 9(8):529-39.
Score: 0.002
-
PBLs of early breast carcinoma patients with a high nuclear grade tumor unlike PBLs of cervical carcinoma patients do not show a decreased TCR zeta expression but are functionally impaired. J Immunother. 1998 Jul; 21(4):317-22.
Score: 0.001
-
Factors that influence biochemical failure after radiation therapy for stage T1c prostate cancer. Am J Clin Oncol. 1998 Feb; 21(1):6-11.
Score: 0.001
-
DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas. Gynecol Oncol. 1993 Feb; 48(2):232-5.
Score: 0.001